Moderna Inc. weekly uptrend opportunity based On 1.00 Lot Calculation:
- Moderna, Inc. a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA (new technology) for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. They are one of the largest suppliers of Covid- 19 vaccine in the world, holding an efficacy rate of around 95%. More than 800 million doses have been already ordered worldwide.
- EVENT: FIRST QUARTER EARNINGS REPORT (Thursday, MAY 6, 2021) (PREMARKET): The company is expected to announce a record revenue figure of 2.3 billion dollars for the first quarter of 2021. Earnings per share are expected to come in positive at $2.44 for the first time ever. Investors will be also careful, trying to get clues about Moderna’s business guidance for the rest of 2021.
- EVENT: MODERNA TESTS COVID- 19 VACCINE ON POPULATION BELOW 17 YEARS OF AGE. FIRST UPDATES COULD BE EXPECTED SOON: Moderna launched a trial at 12 to 17 years old. The largest population on Earth (around 30%) is below 17 so if all goes well this could prove to be a big market for Moderna. Moderna has also begun (March 16) testing its Covid-19 vaccine in children aged 6 months to 11 years of age.
- INDIA AND EU TO INCREASE MODERNA COVID-19 VACCINE ORDERS? : The central government in India (1.3 billion of population) announced a change in its policy (April 13). This new policy potentially opens the door for Covid-19 vaccines from Pfizer and Moderna. The European Union, on the other hand, will shortly sign contracts to purchase up to 1.8 billion doses of coronavirus vaccine from Pfizer and Moderna.
- ASTRAZENECA AND JOHNSON AND JOHNSON COVID- 19 VACCINE ISSUES TO CREATE BIGGER MARKET FOR MODERNA COVID-19 VACCINE: Many EU countries including France, Germany and Italy, restricted their use of AstraZeneca Covid-19 vaccine due to blood clotting issues. In the U.S., Johnson and Johnson vaccine has been suspended by the US FDA on Tuesday (April 13) due to blood clot issues as well.
- PRICE ACTION: Moderna hit a fresh all- time high of $218 in January 2021. At the moment it trades around 20% below its all- time high.
Moderna Inc., (#MODERNA) April 27, 2021
Current Price: 175
|
Moderna Inc. |
Weekly |
|
Trend direction |
|
|
218 |
|
|
205 |
|
|
195 |
|
|
156 |
|
|
150 |
|
|
140 |
Example of calculation base on weekly trend direction for 1.00 Lot*
|
MODERNA INC. |
||||||
|
Pivot Points |
||||||
|
Profit or loss in $ |
43,000.00 |
30,000.00 |
20,000.00 |
-19,000.00 |
-25,000.00 |
-35,000.00 |
|
Profit or loss in €** |
35,645.60 |
24,869.02 |
16,579.35 |
-15,750.38 |
-20,724.19 |
-29,013.86 |
|
Profit or loss in £** |
30,973.58 |
21,609.47 |
14,406.32 |
-13,686.00 |
-18,007.89 |
-25,211.05 |
|
Profit or loss in C$** |
53,371.60 |
37,236.00 |
24,824.00 |
-23,582.80 |
-31,030.00 |
-43,442.00 |
* 1.00 lot is equivalent of 1000 units
** Calculations for exchange rate used as of 11:00 am. (GMT+1) 27/04/2021
Fortrade recommends the use of Stop-Loss and Take-Profit, please speak to your Client Manager regarding their use.
*** You may wish to consider closing your position in profit, even if it is lower than suggested one
**** Trailing stop technique can protect the profit – Ask your Client Manager for more details